AERI - Aerie Pharmaceuticals Non-GAAP EPS of -$0.32 beats by $0.23 revenue of $33.3M beats by $0.71M August, 04 2022 04:02 PM Aerie Pharmaceuticals Inc. Aerie Pharmaceuticals press release ( NASDAQ: AERI ): Q2 Non-GAAP EPS of -$0.32 beats by $0.23 . Revenue of $33.3M (+22.4% Y/Y) beats by $0.71M . For further details see: Aerie Pharmaceuticals Non-GAAP EPS of -$0.32 beats by $0.23, revenue of $33.3M beats by $0.71M